nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—Levorphanol—Estradiol—osteoporosis	0.515	1	CrCrCtD
Dihydrocodeine—CYP3A4—Estropipate—osteoporosis	0.0506	0.158	CbGbCtD
Dihydrocodeine—CYP3A4—Calcitriol—osteoporosis	0.0506	0.158	CbGbCtD
Dihydrocodeine—CYP2D6—Cholecalciferol—osteoporosis	0.041	0.128	CbGbCtD
Dihydrocodeine—CYP3A4—Ergocalciferol—osteoporosis	0.0404	0.126	CbGbCtD
Dihydrocodeine—CYP3A4—Raloxifene—osteoporosis	0.0337	0.105	CbGbCtD
Dihydrocodeine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0326	0.102	CbGbCtD
Dihydrocodeine—CYP3A4—Cholecalciferol—osteoporosis	0.0261	0.0814	CbGbCtD
Dihydrocodeine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0239	0.0748	CbGbCtD
Dihydrocodeine—CYP3A4—Estradiol—osteoporosis	0.021	0.0657	CbGbCtD
Dihydrocodeine—Convulsion—Calcitriol—osteoporosis	0.000685	0.00416	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000683	0.00415	CcSEcCtD
Dihydrocodeine—Constipation—Etidronic acid—osteoporosis	0.000679	0.00413	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Estropipate—osteoporosis	0.000674	0.00409	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.000673	0.00409	CcSEcCtD
Dihydrocodeine—Dry mouth—Ibandronate—osteoporosis	0.000672	0.00408	CcSEcCtD
Dihydrocodeine—Mental disorder—Risedronate—osteoporosis	0.00067	0.00407	CcSEcCtD
Dihydrocodeine—Skin disorder—Estropipate—osteoporosis	0.000668	0.00405	CcSEcCtD
Dihydrocodeine—Angiopathy—Pamidronate—osteoporosis	0.000659	0.004	CcSEcCtD
Dihydrocodeine—Dry mouth—Calcitriol—osteoporosis	0.000658	0.004	CcSEcCtD
Dihydrocodeine—Immune system disorder—Pamidronate—osteoporosis	0.000656	0.00399	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Zoledronate—osteoporosis	0.000656	0.00398	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Pamidronate—osteoporosis	0.000655	0.00398	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Etidronic acid—osteoporosis	0.000655	0.00398	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Raloxifene—osteoporosis	0.000653	0.00397	CcSEcCtD
Dihydrocodeine—Urethral disorder—Zoledronate—osteoporosis	0.000651	0.00395	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00065	0.00395	CcSEcCtD
Dihydrocodeine—Skin disorder—Raloxifene—osteoporosis	0.000647	0.00393	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Ibandronate—osteoporosis	0.000646	0.00393	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Raloxifene—osteoporosis	0.000644	0.00391	CcSEcCtD
Dihydrocodeine—Skin disorder—Ibandronate—osteoporosis	0.00064	0.00389	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Ibandronate—osteoporosis	0.000637	0.00387	CcSEcCtD
Dihydrocodeine—Nausea—Ergocalciferol—osteoporosis	0.000635	0.00386	CcSEcCtD
Dihydrocodeine—Urticaria—Etidronic acid—osteoporosis	0.000631	0.00383	CcSEcCtD
Dihydrocodeine—Abdominal pain—Etidronic acid—osteoporosis	0.000628	0.00381	CcSEcCtD
Dihydrocodeine—Skin disorder—Calcitriol—osteoporosis	0.000627	0.00381	CcSEcCtD
Dihydrocodeine—Angioedema—Ethinyl Estradiol—osteoporosis	0.000624	0.00379	CcSEcCtD
Dihydrocodeine—Paraesthesia—Estropipate—osteoporosis	0.000617	0.00375	CcSEcCtD
Dihydrocodeine—Somnolence—Estropipate—osteoporosis	0.000611	0.00371	CcSEcCtD
Dihydrocodeine—Angioedema—Risedronate—osteoporosis	0.000608	0.00369	CcSEcCtD
Dihydrocodeine—Angiopathy—Zoledronate—osteoporosis	0.000602	0.00366	CcSEcCtD
Dihydrocodeine—Immune system disorder—Zoledronate—osteoporosis	0.0006	0.00364	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Zoledronate—osteoporosis	0.000598	0.00363	CcSEcCtD
Dihydrocodeine—Vertigo—Risedronate—osteoporosis	0.000598	0.00363	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Estropipate—osteoporosis	0.000593	0.0036	CcSEcCtD
Dihydrocodeine—Paraesthesia—Ibandronate—osteoporosis	0.000592	0.00359	CcSEcCtD
Dihydrocodeine—Constipation—Estropipate—osteoporosis	0.000588	0.00357	CcSEcCtD
Dihydrocodeine—Mental disorder—Zoledronate—osteoporosis	0.000582	0.00353	CcSEcCtD
Dihydrocodeine—Angiopathy—Conjugated Estrogens—osteoporosis	0.00058	0.00352	CcSEcCtD
Dihydrocodeine—Constipation—Alendronate—osteoporosis	0.000579	0.00352	CcSEcCtD
Dihydrocodeine—Angioedema—Pamidronate—osteoporosis	0.000578	0.00351	CcSEcCtD
Dihydrocodeine—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000577	0.00351	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000577	0.0035	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000576	0.0035	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000575	0.00349	CcSEcCtD
Dihydrocodeine—Somnolence—Calcitriol—osteoporosis	0.000574	0.00348	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000569	0.00346	CcSEcCtD
Dihydrocodeine—Constipation—Ibandronate—osteoporosis	0.000564	0.00342	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000563	0.00342	CcSEcCtD
Dihydrocodeine—Pruritus—Etidronic acid—osteoporosis	0.000562	0.00341	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Estropipate—osteoporosis	0.000562	0.00341	CcSEcCtD
Dihydrocodeine—Mental disorder—Conjugated Estrogens—osteoporosis	0.00056	0.0034	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Alendronate—osteoporosis	0.000558	0.00339	CcSEcCtD
Dihydrocodeine—Dry mouth—Risedronate—osteoporosis	0.000554	0.00337	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Alendronate—osteoporosis	0.000554	0.00336	CcSEcCtD
Dihydrocodeine—Constipation—Calcitriol—osteoporosis	0.000552	0.00335	CcSEcCtD
Dihydrocodeine—Convulsion—Pamidronate—osteoporosis	0.000548	0.00333	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000546	0.00332	CcSEcCtD
Dihydrocodeine—Urticaria—Estropipate—osteoporosis	0.000546	0.00332	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Raloxifene—osteoporosis	0.000544	0.00331	CcSEcCtD
Dihydrocodeine—Diarrhoea—Etidronic acid—osteoporosis	0.000544	0.0033	CcSEcCtD
Dihydrocodeine—Abdominal pain—Estropipate—osteoporosis	0.000543	0.0033	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Ibandronate—osteoporosis	0.000543	0.0033	CcSEcCtD
Dihydrocodeine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000541	0.00329	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Estradiol—osteoporosis	0.000539	0.00327	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000539	0.00327	CcSEcCtD
Dihydrocodeine—Urticaria—Alendronate—osteoporosis	0.000538	0.00327	CcSEcCtD
Dihydrocodeine—Abdominal pain—Alendronate—osteoporosis	0.000535	0.00325	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Risedronate—osteoporosis	0.000533	0.00323	CcSEcCtD
Dihydrocodeine—Angioedema—Zoledronate—osteoporosis	0.000528	0.00321	CcSEcCtD
Dihydrocodeine—Skin disorder—Risedronate—osteoporosis	0.000528	0.0032	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000528	0.0032	CcSEcCtD
Dihydrocodeine—Abdominal pain—Raloxifene—osteoporosis	0.000526	0.0032	CcSEcCtD
Dihydrocodeine—Urticaria—Ibandronate—osteoporosis	0.000524	0.00318	CcSEcCtD
Dihydrocodeine—Abdominal pain—Ibandronate—osteoporosis	0.000521	0.00316	CcSEcCtD
Dihydrocodeine—Confusional state—Pamidronate—osteoporosis	0.000521	0.00316	CcSEcCtD
Dihydrocodeine—Vertigo—Zoledronate—osteoporosis	0.000519	0.00315	CcSEcCtD
Dihydrocodeine—Urticaria—Calcitriol—osteoporosis	0.000513	0.00311	CcSEcCtD
Dihydrocodeine—Abdominal pain—Calcitriol—osteoporosis	0.00051	0.0031	CcSEcCtD
Dihydrocodeine—Angioedema—Conjugated Estrogens—osteoporosis	0.000508	0.00309	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Pamidronate—osteoporosis	0.000506	0.00308	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Estradiol—osteoporosis	0.000505	0.00307	CcSEcCtD
Dihydrocodeine—Vomiting—Etidronic acid—osteoporosis	0.000505	0.00307	CcSEcCtD
Dihydrocodeine—Urethral disorder—Estradiol—osteoporosis	0.000501	0.00305	CcSEcCtD
Dihydrocodeine—Rash—Etidronic acid—osteoporosis	0.000501	0.00304	CcSEcCtD
Dihydrocodeine—Convulsion—Zoledronate—osteoporosis	0.000501	0.00304	CcSEcCtD
Dihydrocodeine—Dermatitis—Etidronic acid—osteoporosis	0.0005	0.00304	CcSEcCtD
Dihydrocodeine—Vertigo—Conjugated Estrogens—osteoporosis	0.0005	0.00304	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Pamidronate—osteoporosis	0.000499	0.00303	CcSEcCtD
Dihydrocodeine—Headache—Etidronic acid—osteoporosis	0.000498	0.00302	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000489	0.00297	CcSEcCtD
Dihydrocodeine—Paraesthesia—Risedronate—osteoporosis	0.000488	0.00296	CcSEcCtD
Dihydrocodeine—Pruritus—Estropipate—osteoporosis	0.000486	0.00295	CcSEcCtD
Dihydrocodeine—Dyspnoea—Risedronate—osteoporosis	0.000484	0.00294	CcSEcCtD
Dihydrocodeine—Hypotension—Pamidronate—osteoporosis	0.000482	0.00293	CcSEcCtD
Dihydrocodeine—Convulsion—Conjugated Estrogens—osteoporosis	0.000482	0.00293	CcSEcCtD
Dihydrocodeine—Dry mouth—Zoledronate—osteoporosis	0.000481	0.00292	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000481	0.00292	CcSEcCtD
Dihydrocodeine—Pruritus—Alendronate—osteoporosis	0.000479	0.00291	CcSEcCtD
Dihydrocodeine—Constipation—Ethinyl Estradiol—osteoporosis	0.000476	0.00289	CcSEcCtD
Dihydrocodeine—Confusional state—Zoledronate—osteoporosis	0.000476	0.00289	CcSEcCtD
Dihydrocodeine—Nausea—Etidronic acid—osteoporosis	0.000472	0.00287	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00047	0.00286	CcSEcCtD
Dihydrocodeine—Diarrhoea—Estropipate—osteoporosis	0.00047	0.00286	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000469	0.00285	CcSEcCtD
Dihydrocodeine—Pruritus—Ibandronate—osteoporosis	0.000466	0.00283	CcSEcCtD
Dihydrocodeine—Constipation—Risedronate—osteoporosis	0.000464	0.00282	CcSEcCtD
Dihydrocodeine—Angiopathy—Estradiol—osteoporosis	0.000464	0.00282	CcSEcCtD
Dihydrocodeine—Paraesthesia—Pamidronate—osteoporosis	0.000464	0.00282	CcSEcCtD
Dihydrocodeine—Diarrhoea—Alendronate—osteoporosis	0.000463	0.00281	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Zoledronate—osteoporosis	0.000463	0.00281	CcSEcCtD
Dihydrocodeine—Immune system disorder—Estradiol—osteoporosis	0.000462	0.00281	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Estradiol—osteoporosis	0.000461	0.0028	CcSEcCtD
Dihydrocodeine—Dyspnoea—Pamidronate—osteoporosis	0.00046	0.0028	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000459	0.00279	CcSEcCtD
Dihydrocodeine—Somnolence—Pamidronate—osteoporosis	0.000459	0.00279	CcSEcCtD
Dihydrocodeine—Skin disorder—Zoledronate—osteoporosis	0.000458	0.00278	CcSEcCtD
Dihydrocodeine—Pruritus—Calcitriol—osteoporosis	0.000456	0.00277	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Zoledronate—osteoporosis	0.000456	0.00277	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000456	0.00277	CcSEcCtD
Dihydrocodeine—Diarrhoea—Raloxifene—osteoporosis	0.000455	0.00277	CcSEcCtD
Dihydrocodeine—Dizziness—Estropipate—osteoporosis	0.000454	0.00276	CcSEcCtD
Dihydrocodeine—Diarrhoea—Ibandronate—osteoporosis	0.000451	0.00274	CcSEcCtD
Dihydrocodeine—Mental disorder—Estradiol—osteoporosis	0.000448	0.00272	CcSEcCtD
Dihydrocodeine—Dizziness—Alendronate—osteoporosis	0.000448	0.00272	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000446	0.00271	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000445	0.0027	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Risedronate—osteoporosis	0.000444	0.0027	CcSEcCtD
Dihydrocodeine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000443	0.00269	CcSEcCtD
Dihydrocodeine—Constipation—Pamidronate—osteoporosis	0.000442	0.00268	CcSEcCtD
Dihydrocodeine—Diarrhoea—Calcitriol—osteoporosis	0.000441	0.00268	CcSEcCtD
Dihydrocodeine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000441	0.00268	CcSEcCtD
Dihydrocodeine—Hypotension—Zoledronate—osteoporosis	0.000441	0.00268	CcSEcCtD
Dihydrocodeine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00044	0.00267	CcSEcCtD
Dihydrocodeine—Dizziness—Raloxifene—osteoporosis	0.00044	0.00267	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000439	0.00267	CcSEcCtD
Dihydrocodeine—Vomiting—Estropipate—osteoporosis	0.000437	0.00265	CcSEcCtD
Dihydrocodeine—Dizziness—Ibandronate—osteoporosis	0.000436	0.00265	CcSEcCtD
Dihydrocodeine—Rash—Estropipate—osteoporosis	0.000433	0.00263	CcSEcCtD
Dihydrocodeine—Dermatitis—Estropipate—osteoporosis	0.000433	0.00263	CcSEcCtD
Dihydrocodeine—Urticaria—Risedronate—osteoporosis	0.000431	0.00262	CcSEcCtD
Dihydrocodeine—Headache—Estropipate—osteoporosis	0.000431	0.00261	CcSEcCtD
Dihydrocodeine—Vomiting—Alendronate—osteoporosis	0.00043	0.00261	CcSEcCtD
Dihydrocodeine—Abdominal pain—Risedronate—osteoporosis	0.000429	0.00261	CcSEcCtD
Dihydrocodeine—Rash—Alendronate—osteoporosis	0.000427	0.00259	CcSEcCtD
Dihydrocodeine—Dermatitis—Alendronate—osteoporosis	0.000426	0.00259	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Pamidronate—osteoporosis	0.000425	0.00258	CcSEcCtD
Dihydrocodeine—Hypotension—Conjugated Estrogens—osteoporosis	0.000424	0.00258	CcSEcCtD
Dihydrocodeine—Headache—Alendronate—osteoporosis	0.000424	0.00258	CcSEcCtD
Dihydrocodeine—Paraesthesia—Zoledronate—osteoporosis	0.000423	0.00257	CcSEcCtD
Dihydrocodeine—Vomiting—Raloxifene—osteoporosis	0.000423	0.00257	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000422	0.00256	CcSEcCtD
Dihydrocodeine—Dyspnoea—Zoledronate—osteoporosis	0.00042	0.00255	CcSEcCtD
Dihydrocodeine—Rash—Raloxifene—osteoporosis	0.00042	0.00255	CcSEcCtD
Dihydrocodeine—Dermatitis—Raloxifene—osteoporosis	0.000419	0.00255	CcSEcCtD
Dihydrocodeine—Somnolence—Zoledronate—osteoporosis	0.000419	0.00255	CcSEcCtD
Dihydrocodeine—Vomiting—Ibandronate—osteoporosis	0.000419	0.00254	CcSEcCtD
Dihydrocodeine—Headache—Raloxifene—osteoporosis	0.000417	0.00253	CcSEcCtD
Dihydrocodeine—Rash—Ibandronate—osteoporosis	0.000416	0.00252	CcSEcCtD
Dihydrocodeine—Dermatitis—Ibandronate—osteoporosis	0.000415	0.00252	CcSEcCtD
Dihydrocodeine—Headache—Ibandronate—osteoporosis	0.000413	0.00251	CcSEcCtD
Dihydrocodeine—Vomiting—Calcitriol—osteoporosis	0.00041	0.00249	CcSEcCtD
Dihydrocodeine—Nausea—Estropipate—osteoporosis	0.000408	0.00248	CcSEcCtD
Dihydrocodeine—Abdominal pain—Pamidronate—osteoporosis	0.000408	0.00248	CcSEcCtD
Dihydrocodeine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000408	0.00248	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000407	0.00247	CcSEcCtD
Dihydrocodeine—Angioedema—Estradiol—osteoporosis	0.000407	0.00247	CcSEcCtD
Dihydrocodeine—Rash—Calcitriol—osteoporosis	0.000407	0.00247	CcSEcCtD
Dihydrocodeine—Dermatitis—Calcitriol—osteoporosis	0.000406	0.00247	CcSEcCtD
Dihydrocodeine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000405	0.00246	CcSEcCtD
Dihydrocodeine—Headache—Calcitriol—osteoporosis	0.000404	0.00245	CcSEcCtD
Dihydrocodeine—Somnolence—Conjugated Estrogens—osteoporosis	0.000404	0.00245	CcSEcCtD
Dihydrocodeine—Constipation—Zoledronate—osteoporosis	0.000403	0.00245	CcSEcCtD
Dihydrocodeine—Nausea—Alendronate—osteoporosis	0.000402	0.00244	CcSEcCtD
Dihydrocodeine—Vertigo—Estradiol—osteoporosis	0.0004	0.00243	CcSEcCtD
Dihydrocodeine—Nausea—Raloxifene—osteoporosis	0.000395	0.0024	CcSEcCtD
Dihydrocodeine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000394	0.00239	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000392	0.00238	CcSEcCtD
Dihydrocodeine—Nausea—Ibandronate—osteoporosis	0.000391	0.00238	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Zoledronate—osteoporosis	0.000389	0.00236	CcSEcCtD
Dihydrocodeine—Constipation—Conjugated Estrogens—osteoporosis	0.000388	0.00236	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000386	0.00234	CcSEcCtD
Dihydrocodeine—Pruritus—Risedronate—osteoporosis	0.000384	0.00233	CcSEcCtD
Dihydrocodeine—Nausea—Calcitriol—osteoporosis	0.000383	0.00233	CcSEcCtD
Dihydrocodeine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000381	0.00231	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000377	0.00229	CcSEcCtD
Dihydrocodeine—Urticaria—Zoledronate—osteoporosis	0.000375	0.00228	CcSEcCtD
Dihydrocodeine—Abdominal pain—Zoledronate—osteoporosis	0.000373	0.00226	CcSEcCtD
Dihydrocodeine—Diarrhoea—Risedronate—osteoporosis	0.000372	0.00226	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000371	0.00226	CcSEcCtD
Dihydrocodeine—Dry mouth—Estradiol—osteoporosis	0.000371	0.00225	CcSEcCtD
Dihydrocodeine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000368	0.00224	CcSEcCtD
Dihydrocodeine—Confusional state—Estradiol—osteoporosis	0.000366	0.00223	CcSEcCtD
Dihydrocodeine—Pruritus—Pamidronate—osteoporosis	0.000365	0.00222	CcSEcCtD
Dihydrocodeine—Urticaria—Conjugated Estrogens—osteoporosis	0.000361	0.00219	CcSEcCtD
Dihydrocodeine—Dizziness—Risedronate—osteoporosis	0.000359	0.00218	CcSEcCtD
Dihydrocodeine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000359	0.00218	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Estradiol—osteoporosis	0.000356	0.00216	CcSEcCtD
Dihydrocodeine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000354	0.00215	CcSEcCtD
Dihydrocodeine—Diarrhoea—Pamidronate—osteoporosis	0.000353	0.00215	CcSEcCtD
Dihydrocodeine—Skin disorder—Estradiol—osteoporosis	0.000353	0.00214	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Estradiol—osteoporosis	0.000351	0.00213	CcSEcCtD
Dihydrocodeine—Rash—Ethinyl Estradiol—osteoporosis	0.000351	0.00213	CcSEcCtD
Dihydrocodeine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000351	0.00213	CcSEcCtD
Dihydrocodeine—Headache—Ethinyl Estradiol—osteoporosis	0.000349	0.00212	CcSEcCtD
Dihydrocodeine—Vomiting—Risedronate—osteoporosis	0.000345	0.0021	CcSEcCtD
Dihydrocodeine—Rash—Risedronate—osteoporosis	0.000342	0.00208	CcSEcCtD
Dihydrocodeine—Dermatitis—Risedronate—osteoporosis	0.000342	0.00208	CcSEcCtD
Dihydrocodeine—Dizziness—Pamidronate—osteoporosis	0.000341	0.00207	CcSEcCtD
Dihydrocodeine—Headache—Risedronate—osteoporosis	0.00034	0.00207	CcSEcCtD
Dihydrocodeine—Pruritus—Zoledronate—osteoporosis	0.000334	0.00203	CcSEcCtD
Dihydrocodeine—Nausea—Ethinyl Estradiol—osteoporosis	0.000331	0.00201	CcSEcCtD
Dihydrocodeine—Vomiting—Pamidronate—osteoporosis	0.000328	0.00199	CcSEcCtD
Dihydrocodeine—Paraesthesia—Estradiol—osteoporosis	0.000326	0.00198	CcSEcCtD
Dihydrocodeine—Rash—Pamidronate—osteoporosis	0.000326	0.00198	CcSEcCtD
Dihydrocodeine—Dermatitis—Pamidronate—osteoporosis	0.000325	0.00198	CcSEcCtD
Dihydrocodeine—Dyspnoea—Estradiol—osteoporosis	0.000324	0.00197	CcSEcCtD
Dihydrocodeine—Headache—Pamidronate—osteoporosis	0.000323	0.00196	CcSEcCtD
Dihydrocodeine—Somnolence—Estradiol—osteoporosis	0.000323	0.00196	CcSEcCtD
Dihydrocodeine—Diarrhoea—Zoledronate—osteoporosis	0.000323	0.00196	CcSEcCtD
Dihydrocodeine—Nausea—Risedronate—osteoporosis	0.000323	0.00196	CcSEcCtD
Dihydrocodeine—Pruritus—Conjugated Estrogens—osteoporosis	0.000321	0.00195	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000314	0.00191	CcSEcCtD
Dihydrocodeine—Dizziness—Zoledronate—osteoporosis	0.000312	0.00189	CcSEcCtD
Dihydrocodeine—Constipation—Estradiol—osteoporosis	0.000311	0.00189	CcSEcCtD
Dihydrocodeine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000311	0.00189	CcSEcCtD
Dihydrocodeine—Nausea—Pamidronate—osteoporosis	0.000307	0.00186	CcSEcCtD
Dihydrocodeine—Dizziness—Conjugated Estrogens—osteoporosis	0.0003	0.00182	CcSEcCtD
Dihydrocodeine—Vomiting—Zoledronate—osteoporosis	0.0003	0.00182	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Estradiol—osteoporosis	0.000299	0.00182	CcSEcCtD
Dihydrocodeine—Rash—Zoledronate—osteoporosis	0.000297	0.00181	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Estradiol—osteoporosis	0.000297	0.0018	CcSEcCtD
Dihydrocodeine—Dermatitis—Zoledronate—osteoporosis	0.000297	0.0018	CcSEcCtD
Dihydrocodeine—Headache—Zoledronate—osteoporosis	0.000295	0.00179	CcSEcCtD
Dihydrocodeine—Vomiting—Conjugated Estrogens—osteoporosis	0.000289	0.00175	CcSEcCtD
Dihydrocodeine—Urticaria—Estradiol—osteoporosis	0.000289	0.00175	CcSEcCtD
Dihydrocodeine—Abdominal pain—Estradiol—osteoporosis	0.000287	0.00174	CcSEcCtD
Dihydrocodeine—Rash—Conjugated Estrogens—osteoporosis	0.000286	0.00174	CcSEcCtD
Dihydrocodeine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000286	0.00174	CcSEcCtD
Dihydrocodeine—Headache—Conjugated Estrogens—osteoporosis	0.000284	0.00173	CcSEcCtD
Dihydrocodeine—Nausea—Zoledronate—osteoporosis	0.00028	0.0017	CcSEcCtD
Dihydrocodeine—Nausea—Conjugated Estrogens—osteoporosis	0.00027	0.00164	CcSEcCtD
Dihydrocodeine—Pruritus—Estradiol—osteoporosis	0.000257	0.00156	CcSEcCtD
Dihydrocodeine—Diarrhoea—Estradiol—osteoporosis	0.000249	0.00151	CcSEcCtD
Dihydrocodeine—Dizziness—Estradiol—osteoporosis	0.00024	0.00146	CcSEcCtD
Dihydrocodeine—Vomiting—Estradiol—osteoporosis	0.000231	0.0014	CcSEcCtD
Dihydrocodeine—Rash—Estradiol—osteoporosis	0.000229	0.00139	CcSEcCtD
Dihydrocodeine—Dermatitis—Estradiol—osteoporosis	0.000229	0.00139	CcSEcCtD
Dihydrocodeine—Headache—Estradiol—osteoporosis	0.000228	0.00138	CcSEcCtD
Dihydrocodeine—Nausea—Estradiol—osteoporosis	0.000216	0.00131	CcSEcCtD
